| Year |
Citation |
Score |
| 2017 |
Nairz M, Haschka D, Dichtl S, Sonnweber T, Schroll A, Aßhoff M, Mindur JE, Moser PL, Wolf D, Swirski FK, Theurl I, Cerami A, Brines M, Weiss G. Cibinetide dampens innate immune cell functions thus ameliorating the course of experimental colitis. Scientific Reports. 7: 13012. PMID 29026145 DOI: 10.1038/S41598-017-13046-3 |
0.338 |
|
| 2015 |
Collino M, Thiemermann C, Cerami A, Brines M. Flipping the molecular switch for innate protection and repair of tissues: Long-lasting effects of a non-erythropoietic small peptide engineered from erythropoietin. Pharmacology & Therapeutics. 151: 32-40. PMID 25728128 DOI: 10.1016/J.Pharmthera.2015.02.005 |
0.312 |
|
| 2013 |
Ueba H, Shiomi M, Brines M, Yamin M, Kobayashi T, Ako J, Momomura S, Cerami A, Kawakami M. Suppression of coronary atherosclerosis by helix B surface Peptide, a nonerythropoietic, tissue-protective compound derived from erythropoietin. Molecular Medicine (Cambridge, Mass.). 19: 195-202. PMID 23648638 DOI: 10.2119/Molmed.2013.00037 |
0.309 |
|
| 2008 |
Beutler B, Milsark IW, Cerami AC. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science, 1985, 229(4716):869-871. Classical article. Journal of Immunology (Baltimore, Md. : 1950). 181: 7-9. PMID 18566363 |
0.413 |
|
| 2008 |
Taoufik E, Petit E, Divoux D, Tseveleki V, Mengozzi M, Roberts ML, Valable S, Ghezzi P, Quackenbush J, Brines M, Cerami A, Probert L. TNF receptor I sensitizes neurons to erythropoietin- and VEGF-mediated neuroprotection after ischemic and excitotoxic injury. Proceedings of the National Academy of Sciences of the United States of America. 105: 6185-90. PMID 18413601 DOI: 10.1073/Pnas.0801447105 |
0.313 |
|
| 2006 |
Brines M, Cerami A. Discovering erythropoietin's extra-hematopoietic functions: biology and clinical promise. Kidney International. 70: 246-50. PMID 16738535 DOI: 10.1038/Sj.Ki.5001546 |
0.333 |
|
| 2006 |
Savino C, Pedotti R, Baggi F, Ubiali F, Gallo B, Nava S, Bigini P, Barbera S, Fumagalli E, Mennini T, Vezzani A, Rizzi M, Coleman T, Cerami A, Brines M, et al. Delayed administration of erythropoietin and its non-erythropoietic derivatives ameliorates chronic murine autoimmune encephalomyelitis. Journal of Neuroimmunology. 172: 27-37. PMID 16337691 DOI: 10.1016/J.Jneuroim.2005.10.016 |
0.31 |
|
| 2005 |
Ghezzi P, Cerami A. Tumor necrosis factor as a pharmacological target. Molecular Biotechnology. 31: 239-44. PMID 16230774 DOI: 10.1385/Mb:31:3:239 |
0.34 |
|
| 2005 |
Beutler B, Cerami A. Cachectin--Tumour necrosis factor: a cytokine that mediates injury initiated by invasive parasites. Parasitology Today (Personal Ed.). 3: 345-6. PMID 15462882 DOI: 10.1016/0169-4758(87)90119-0 |
0.498 |
|
| 2004 |
Brines M, Grasso G, Fiordaliso F, Sfacteria A, Ghezzi P, Fratelli M, Latini R, Xie QW, Smart J, Su-Rick CJ, Pobre E, Diaz D, Gomez D, Hand C, Coleman T, ... Cerami A, et al. Erythropoietin mediates tissue protection through an erythropoietin and common beta-subunit heteroreceptor. Proceedings of the National Academy of Sciences of the United States of America. 101: 14907-12. PMID 15456912 DOI: 10.1073/Pnas.0406491101 |
0.31 |
|
| 2004 |
Ghezzi P, Cerami A. Tumor necrosis factor as a pharmacological target. Methods in Molecular Medicine. 98: 1-8. PMID 15064428 DOI: 10.1385/1-59259-771-8:001 |
0.332 |
|
| 2003 |
Villa P, Bigini P, Mennini T, Agnello D, Laragione T, Cagnotto A, Viviani B, Marinovich M, Cerami A, Coleman TR, Brines M, Ghezzi P. Erythropoietin selectively attenuates cytokine production and inflammation in cerebral ischemia by targeting neuronal apoptosis. The Journal of Experimental Medicine. 198: 971-5. PMID 12975460 DOI: 10.1084/Jem.20021067 |
0.306 |
|
| 2003 |
Erbayraktar S, Grasso G, Sfacteria A, Xie QW, Coleman T, Kreilgaard M, Torup L, Sager T, Erbayraktar Z, Gokmen N, Yilmaz O, Ghezzi P, Villa P, Fratelli M, Casagrande S, ... ... Cerami A, et al. Asialoerythropoietin is a nonerythropoietic cytokine with broad neuroprotective activity in vivo. Proceedings of the National Academy of Sciences of the United States of America. 100: 6741-6. PMID 12746497 DOI: 10.1073/Pnas.1031753100 |
0.321 |
|
| 2003 |
Calvillo L, Latini R, Kajstura J, Leri A, Anversa P, Ghezzi P, Salio M, Cerami A, Brines M. Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling. Proceedings of the National Academy of Sciences of the United States of America. 100: 4802-6. PMID 12663857 DOI: 10.1073/Pnas.0630444100 |
0.302 |
|
| 2002 |
Agnello D, Bigini P, Villa P, Mennini T, Cerami A, Brines ML, Ghezzi P. Erythropoietin exerts an anti-inflammatory effect on the CNS in a model of experimental autoimmune encephalomyelitis. Brain Research. 952: 128-34. PMID 12363412 DOI: 10.1016/S0006-8993(02)03239-0 |
0.306 |
|
| 1996 |
Vasan S, Zhang X, Zhang X, Kapurniotu A, Bernhagen J, Teichberg S, Basgen J, Wagle D, Shih D, Terlecky I, Bucala R, Cerami A, Egan J, Ulrich P. An agent cleaving glucose-derived protein crosslinks in vitro and in vivo. Nature. 382: 275-8. PMID 8717046 DOI: 10.1038/382275A0 |
0.322 |
|
| 1995 |
Palinski W, Koschinsky T, Butler SW, Miller E, Vlassara H, Cerami A, Witztum JL. Immunological evidence for the presence of advanced glycosylation end products in atherosclerotic lesions of euglycemic rabbits Arteriosclerosis, Thrombosis, and Vascular Biology. 15: 571-582. PMID 7749871 DOI: 10.1161/01.Atv.15.5.571 |
0.3 |
|
| 1995 |
Calandra T, Bernhagen J, Metz CN, Spiegel LA, Bacher M, Donnelly T, Cerami A, Bucala R. MIF as a glucocorticoid-induced modulator of cytokine production. Nature. 377: 68-71. PMID 7659164 DOI: 10.1038/377068A0 |
0.342 |
|
| 1995 |
Bianchi M, Ulrich P, Bloom O, Meistrell M, Zimmerman GA, Schmidtmayerova H, Bukrinsky M, Donnelley T, Bucala R, Sherry B, Manogue KR, Tortolani AJ, Cerami A, Tracey KJ. An inhibitor of macrophage arginine transport and nitric oxide production (CNI-1493) prevents acute inflammation and endotoxin lethality. Molecular Medicine. 1: 254-266. DOI: 10.1007/Bf03401550 |
0.323 |
|
| 1994 |
Bernhagen J, Calandra T, Cerami A, Bucala R. Macrophage migration inhibitory factor is a neuroendocrine mediator of endotoxaemia Trends in Microbiology. 2: 198-201. PMID 8087451 DOI: 10.1016/0966-842X(94)90111-H |
0.316 |
|
| 1994 |
Hogan M, Sherry B, Ritchlin C, Fabre M, Winchester R, Cerami A, Bucala R. Differential expression of the small inducible cytokines GRO α and GROβ by synovial fibroblasts in chronic arthritis: Possible role in growth regulation Cytokine. 6: 61-69. PMID 8003635 DOI: 10.1016/1043-4666(94)90009-4 |
0.302 |
|
| 1994 |
Bernhagen J, Mitchell RA, Calandra T, Voelter W, Cerami A, Bucala R. Purification, bioactivity, and secondary structure analysis of mouse and human macrophage Migration Inhibitory Factor (MIF) Biochemistry. 33: 14144-14155. PMID 7947826 DOI: 10.1021/Bi00251A025 |
0.359 |
|
| 1994 |
Bucala R, Vlassara H, Cerami A. Advanced glycosylation endproducts: Role in diabetic and non-diabetic vascular disease Drug Development Research. 32: 77-89. DOI: 10.1002/Ddr.430320204 |
0.305 |
|
| 1993 |
Tracey KJ, Cerami A. Tumor necrosis factor, other cytokines and disease Annual Review of Cell Biology. 9: 317-343. PMID 8280464 DOI: 10.1146/Annurev.Cb.09.110193.001533 |
0.33 |
|
| 1993 |
Zentella A, Manogue K, Cerami A. Cachectin/TNF-mediated lactate production in cultured myocytes is linked to activation of a futile substrate cycle. Cytokine. 5: 436-47. PMID 8142598 DOI: 10.1016/1043-4666(93)90033-2 |
0.309 |
|
| 1992 |
Sherry B, Yarlett N, Strupp A, Cerami A. Identification of cyclophilin as a proinflammatory secretory product of lipopolysaccharide-activated macrophages Proceedings of the National Academy of Sciences of the United States of America. 89: 3511-3515. PMID 1565646 DOI: 10.1073/Pnas.89.8.3511 |
0.327 |
|
| 1992 |
Hogan M, Cerami A, Bucala R. Advanced glycosylation endproducts block the antiproliferative effect of nitric oxide: Role in the vascular and renal complications of diabetes mellitus Journal of Clinical Investigation. 90: 1110-1115. PMID 1522220 DOI: 10.1172/Jci115928 |
0.302 |
|
| 1991 |
Sherry B, Cerami A. Small cytokine superfamily Current Opinion in Immunology. 3: 56-60. PMID 2054114 DOI: 10.1016/0952-7915(91)90077-E |
0.313 |
|
| 1991 |
Yang Z, Makita Z, Horii Y, Brunelle S, Cerami A, Sehajpal P, Suthanthiran M, Vlassara H. Two novel rat liver membrane proteins that bind advanced glycosylation endproducts: Relationship to macrophage receptor for glucose-modified proteins Journal of Experimental Medicine. 174: 515-524. PMID 1651976 DOI: 10.1084/Jem.174.3.515 |
0.31 |
|
| 1990 |
Tracey KJ, Cerami A. Studies of cachexia in parasitic infection. Annals of the New York Academy of Sciences. 569: 211-8. PMID 2698089 DOI: 10.1111/J.1749-6632.1989.Tb27371.X |
0.347 |
|
| 1990 |
Saukkonen K, Sande S, Cioffe C, Wolpe S, Sherry B, Cerami A, Tuomanen E. The role of cytokines in the generation of inflammation and tissue damage in experimental gram-positive meningitis. The Journal of Experimental Medicine. 171: 439-48. PMID 2406363 DOI: 10.1084/Jem.171.2.439 |
0.314 |
|
| 1990 |
Sherry B, Jue DM, Zentella A, Cerami A. Characterization of high molecular weight glycosylated forms of murine tumor necrosis factor Biochemical and Biophysical Research Communications. 173: 1072-1078. PMID 2268312 DOI: 10.1016/S0006-291X(05)80895-2 |
0.344 |
|
| 1990 |
Tracey KJ, Morgello S, Koplin B, Fahey TJ, Fox J, Aledo A, Manogue KR, Cerami A. Metabolic effects of cachectin/tumor necrosis factor are modified by site of production. Cachectin/tumor necrosis factor-secreting tumor in skeletal muscle induces chronic cachexia, while implantation in brain induces predominantly acute anorexia. The Journal of Clinical Investigation. 86: 2014-24. PMID 2254457 DOI: 10.1172/Jci114937 |
0.33 |
|
| 1990 |
Jue DM, Sherry B, Luedke C, Manogue KR, Cerami A. Processing of newly synthesized cachectin/tumor necrosis factor in endotoxin-stimulated macrophages. Biochemistry. 29: 8371-7. PMID 2252898 DOI: 10.1021/Bi00488A025 |
0.343 |
|
| 1990 |
Radoff S, Cerami A, Vlassara H. Isolation of surface binding protein specific for advanced glycosylation end products from mouse macrophage-derived cell line RAW 267.7 Diabetes. 39: 1510-1518. PMID 2174009 DOI: 10.2337/Diab.39.12.1510 |
0.304 |
|
| 1990 |
Luedke CE, Cerami A. Interferon-gamma overcomes glucocorticoid suppression of cachectin/tumor necrosis factor biosynthesis by murine macrophages. The Journal of Clinical Investigation. 86: 1234-40. PMID 2120285 DOI: 10.1172/Jci114829 |
0.33 |
|
| 1989 |
Cerami A, Beutler B. The role of cachectin/TNF in endotoxic shock and cachexia. Immunology Today. 9: 28-31. PMID 3076757 DOI: 10.1016/0167-5699(88)91353-9 |
0.446 |
|
| 1989 |
Fong Y, Lowry SF, Cerami A. Cachetin/TNF: a macrophage protein that induces cachexia and shock. Jpen. Journal of Parenteral and Enteral Nutrition. 12: 72S-77S. PMID 3063842 DOI: 10.1177/014860718801200608 |
0.32 |
|
| 1989 |
Beutler B, Cerami A. The history, properties, and biological effects of cachectin. Biochemistry. 27: 7575-82. PMID 3061461 DOI: 10.1021/Bi00420A001 |
0.442 |
|
| 1989 |
Silen ML, Hesse DG, Felsen D, Moldawer LL, Calvano SE, Seniuk S, Cerami A, Lowry SF. Cachectin/tumor necrosis factor production by fetal and newborn rat hepatic macrophages. Journal of Pediatric Surgery. 24: 34-8; Discussion 38. PMID 2723990 DOI: 10.1016/S0022-3468(89)80296-9 |
0.331 |
|
| 1989 |
Wolpe SD, Cerami A. Macrophage inflammatory proteins 1 and 2: members of a novel superfamily of cytokines. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 3: 2565-73. PMID 2687068 DOI: 10.1096/Fasebj.3.14.2687068 |
0.323 |
|
| 1989 |
Tracey KJ, Cerami A. Cachectin/tumor necrosis factor and other cytokines in infectious disease. Current Opinion in Immunology. 1: 454-61. PMID 2679705 DOI: 10.1016/0952-7915(88)90026-X |
0.344 |
|
| 1989 |
Davatelis G, Wolpe SD, Sherry B, Dayer JM, Chicheportiche R, Cerami A. Macrophage inflammatory protein-1: a prostaglandin-independent endogenous pyrogen. Science (New York, N.Y.). 243: 1066-8. PMID 2646711 DOI: 10.1126/Science.2646711 |
0.344 |
|
| 1989 |
Wolpe SD, Sherry B, Juers D, Davatelis G, Yurt RW, Cerami A. Identification and characterization of macrophage inflammatory protein 2. Proceedings of the National Academy of Sciences of the United States of America. 86: 612-6. PMID 2643119 DOI: 10.1073/Pnas.86.2.612 |
0.324 |
|
| 1989 |
Beutler B, Cerami A. The biology of cachectin/TNF--a primary mediator of the host response. Annual Review of Immunology. 7: 625-55. PMID 2540776 DOI: 10.1146/Annurev.Iy.07.040189.003205 |
0.515 |
|
| 1988 |
Tracey KJ, Wei H, Manogue KR, Fong Y, Hesse DG, Nguyen HT, Kuo GC, Beutler B, Cotran RS, Cerami A. Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation. The Journal of Experimental Medicine. 167: 1211-27. PMID 3351436 DOI: 10.1084/Jem.167.3.1211 |
0.464 |
|
| 1988 |
Davatelis G, Tekamp-Olson P, Wolpe SD, Hermsen K, Luedke C, Gallegos C, Coit D, Merryweather J, Cerami A. Cloning and characterization of a cDNA for murine macrophage inflammatory protein (MIP), a novel monokine with inflammatory and chemokinetic properties. The Journal of Experimental Medicine. 167: 1939-44. PMID 3290382 DOI: 10.1084/Jem.167.6.1939 |
0.314 |
|
| 1988 |
Beutler B, Cerami A. Cachectin, cachexia, and shock. Annual Review of Medicine. 39: 75-83. PMID 3285792 DOI: 10.1146/Annurev.Me.39.020188.000451 |
0.516 |
|
| 1988 |
Wolpe SD, Davatelis G, Sherry B, Beutler B, Hesse DG, Nguyen HT, Moldawer LL, Nathan CF, Lowry SF, Cerami A. Macrophages secrete a novel heparin-binding protein with inflammatory and neutrophil chemokinetic properties. The Journal of Experimental Medicine. 167: 570-81. PMID 3279154 DOI: 10.1084/Jem.167.2.570 |
0.534 |
|
| 1988 |
Sherry B, Tekamp-Olson P, Gallegos C, Bauer D, Davatelis G, Wolpe SD, Masiarz F, Coit D, Cerami A. Resolution of the two components of macrophage inflammatory protein 1, and cloning and characterization of one of those components, macrophage inflammatory protein 1 beta. The Journal of Experimental Medicine. 168: 2251-9. PMID 3058856 DOI: 10.1084/Jem.168.6.2251 |
0.305 |
|
| 1988 |
Beutler B, Cerami A. Tumor necrosis, cachexia, shock, and inflammation: a common mediator. Annual Review of Biochemistry. 57: 505-18. PMID 3052281 DOI: 10.1146/Annurev.Bi.57.070188.002445 |
0.484 |
|
| 1988 |
Sherry B, Cerami A. Cachectin/tumor necrosis factor exerts endocrine, paracrine, and autocrine control of inflammatory responses Journal of Cell Biology. 107: 1269-1277. PMID 3049617 DOI: 10.1083/Jcb.107.4.1269 |
0.377 |
|
| 1988 |
Vlassara H, Brownlee M, Cerami A. Specific macrophage receptor activity for advanced glycosylation end products inversely correlates with insulin levels in vivo Diabetes. 37: 456-461. PMID 2837419 DOI: 10.2337/Diab.37.4.456 |
0.31 |
|
| 1988 |
Michie HR, Manogue KR, Spriggs DR, Revhaug A, O'Dwyer S, Dinarello CA, Cerami A, Wolff SM, Wilmore DW. Detection of circulating tumor necrosis factor after endotoxin administration. The New England Journal of Medicine. 318: 1481-6. PMID 2835680 DOI: 10.1056/Nejm198806093182301 |
0.316 |
|
| 1988 |
Beutler B, Cerami A. The common mediator of shock, cachexia, and tumor necrosis. Advances in Immunology. 42: 213-31. PMID 2834923 DOI: 10.1016/S0065-2776(08)60846-9 |
0.529 |
|
| 1988 |
BEUTLER B, CERAMI A. Cachectin (Tumor Necrosis Factor): A Macrophage Hormone Governing Cellular Metabolism and Inflammatory Response Endocrine Reviews. 9: 57-66. DOI: 10.1210/Edrv-9-1-57 |
0.538 |
|
| 1987 |
Hotez PJ, Le Trang N, Cerami A. Hookworm antigens: the potential for vaccination. Parasitology Today (Personal Ed.). 3: 247-9. PMID 15462967 DOI: 10.1016/0169-4758(87)90148-7 |
0.407 |
|
| 1987 |
Beutler B, Cerami A. Cachectin: more than a tumor necrosis factor. The New England Journal of Medicine. 316: 379-85. PMID 3543677 DOI: 10.1056/Nejm198702123160705 |
0.488 |
|
| 1987 |
Cerami A, Beutler B. Cachectin: the dark side of tumor necrosis factor. Cold Spring Harbor Symposia On Quantitative Biology. 625-9. PMID 3472741 DOI: 10.1101/Sqb.1986.051.01.074 |
0.463 |
|
| 1987 |
Lee MD, Zentella A, Vine W, Pekala PH, Cerami A. Effect of endotoxin-induced monokines on glucose metabolism in the muscle cell line L6. Proceedings of the National Academy of Sciences of the United States of America. 84: 2590-4. PMID 3472226 DOI: 10.1073/Pnas.84.9.2590 |
0.302 |
|
| 1987 |
Cerami A, Tracey KJ, Lowry SF, Beutler B. Cachectin: a pluripotent hormone released during the host response to invasion. Recent Progress in Hormone Research. 43: 99-112. PMID 3306842 DOI: 10.1016/B978-0-12-571143-2.50009-5 |
0.517 |
|
| 1987 |
Beutler B, Cerami A. Cachectin/tumor necrosis factor: an endogenous mediator of shock and inflammation. Immunologic Research. 5: 281-93. PMID 3036973 DOI: 10.1007/Bf02935501 |
0.518 |
|
| 1986 |
Tracey KJ, Lowry SF, Beutler B, Cerami A, Albert JD, Shires GT. Cachectin/tumor necrosis factor mediates changes of skeletal muscle plasma membrane potential. The Journal of Experimental Medicine. 164: 1368-73. PMID 3760781 DOI: 10.1084/Jem.164.4.1368 |
0.402 |
|
| 1986 |
Beutler B, Krochin N, Milsark IW, Luedke C, Cerami A. Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance. Science (New York, N.Y.). 232: 977-80. PMID 3754653 DOI: 10.1126/Science.3754653 |
0.514 |
|
| 1986 |
Cerami A, Vlassara H, Brownlee M. Role of nonenzymatic glycosylation in atherogenesis Journal of Cellular Biochemistry. 30: 111-120. PMID 3517022 DOI: 10.1002/Jcb.240300203 |
0.312 |
|
| 1986 |
Dinarello CA, Cannon JG, Wolff SM, Bernheim HA, Beutler B, Cerami A, Figari IS, Palladino MA, O'Connor JV. Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1. The Journal of Experimental Medicine. 163: 1433-50. PMID 3486936 DOI: 10.1084/Jem.163.6.1433 |
0.484 |
|
| 1986 |
Beutler B, Tkacenko V, Milsark I, Krochin N, Cerami A. Effect of gamma interferon on cachectin expression by mononuclear phagocytes. Reversal of the lpsd (endotoxin resistance) phenotype. The Journal of Experimental Medicine. 164: 1791-6. PMID 3095481 DOI: 10.1084/Jem.164.5.1791 |
0.423 |
|
| 1986 |
Beutler B, Cerami A. Cachectin and tumour necrosis factor as two sides of the same biological coin. Nature. 320: 584-8. PMID 3010124 DOI: 10.1038/320584A0 |
0.506 |
|
| 1986 |
Dayer JM, Beutler B, Cerami A. Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts. The Journal of Experimental Medicine. 162: 2163-8. PMID 2999289 DOI: 10.1084/Jem.162.6.2163 |
0.525 |
|
| 1986 |
Caput D, Beutler B, Hartog K, Thayer R, Brown-Shimer S, Cerami A. Identification of a common nucleotide sequence in the 3'-untranslated region of mRNA molecules specifying inflammatory mediators Proceedings of the National Academy of Sciences of the United States of America. 83: 1670-1674. PMID 2419912 DOI: 10.1073/Pnas.83.6.1670 |
0.475 |
|
| 1985 |
Bucala R, Manabe S, Urban RC, Cerami A. Nonenzymatic modification of lens crystallins by prednisolone induces sulfhydryl oxidation and aggregate formation: in vitro and in vivo studies. Experimental Eye Research. 41: 353-63. PMID 4065253 DOI: 10.1016/S0014-4835(85)80026-9 |
0.305 |
|
| 1985 |
Mahoney JR, Beutler BA, Le Trang N, Vine W, Ikeda Y, Kawakami M, Cerami A. Lipopolysaccharide-treated RAW 264.7 cells produce a mediator that inhibits lipoprotein lipase in 3T3-L1 cells. Journal of Immunology (Baltimore, Md. : 1950). 134: 1673-5. PMID 3968430 |
0.43 |
|
| 1985 |
Cerami A, Ikeda Y, Le Trang N, Hotez PJ, Beutler B. Weight loss associated with an endotoxin-induced mediator from peritoneal macrophages: the role of cachectin (tumor necrosis factor). Immunology Letters. 11: 173-7. PMID 3910566 DOI: 10.1016/0165-2478(85)90165-8 |
0.604 |
|
| 1985 |
Cerami A, Vlassara H, Brownlee M. Protein glycosylation and the pathogenesis of atherosclerosis Metabolism: Clinical and Experimental. 34: 37-42. PMID 3906359 DOI: 10.1016/S0026-0495(85)80008-1 |
0.326 |
|
| 1985 |
Beutler B, Milsark IW, Cerami AC. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science (New York, N.Y.). 229: 869-71. PMID 3895437 DOI: 10.1126/Science.3895437 |
0.505 |
|
| 1985 |
Hotez PJ, Trang NL, McKerrow JH, Cerami A. Isolation and characterization of a proteolytic enzyme from the adult hookworm Ancylostoma caninum. The Journal of Biological Chemistry. 260: 7343-8. PMID 3888998 |
0.356 |
|
| 1985 |
Beutler B, Mahoney J, Le Trang N, Pekala P, Cerami A. Purification of cachectin, a lipoprotein lipase-suppressing hormone secreted by endotoxin-induced RAW 264.7 cells. The Journal of Experimental Medicine. 161: 984-95. PMID 3872925 DOI: 10.1084/Jem.161.5.984 |
0.461 |
|
| 1985 |
Torti FM, Dieckmann B, Beutler B, Cerami A, Ringold GM. A macrophage factor inhibits adipocyte gene expression: an in vitro model of cachexia Science. 229: 867-869. PMID 3839597 DOI: 10.1126/Science.3839597 |
0.496 |
|
| 1985 |
Beutler BA, Milsark IW, Cerami A. Cachectin/tumor necrosis factor: production, distribution, and metabolic fate in vivo. Journal of Immunology (Baltimore, Md. : 1950). 135: 3972-7. PMID 2999236 |
0.452 |
|
| 1985 |
Beutler BA, Cerami A. Recombinant interleukin 1 suppresses lipoprotein lipase activity in 3T3-L1 cells. Journal of Immunology (Baltimore, Md. : 1950). 135: 3969-71. PMID 2999235 |
0.434 |
|
| 1985 |
Beutler B, Greenwald D, Hulmes JD, Chang M, Pan YC, Mathison J, Ulevitch R, Cerami A. Identity of tumour necrosis factor and the macrophage-secreted factor cachectin. Nature. 316: 552-4. PMID 2993897 DOI: 10.1038/316552A0 |
0.541 |
|
| 1984 |
Brownlee M, Vlassara H, Cerami A. Inhibition of heparin-catalyzed human antithrombin III activity by nonenzymatic glycosylation. Possible role in fibrin deposition in diabetes Diabetes. 33: 532-535. PMID 6724150 DOI: 10.2337/Diab.33.6.532 |
0.306 |
|
| 1984 |
Brownlee M, Vlassara H, Cerami A. Nonenzymatic glycosylation and the pathogenesis of diabetic complications Annals of Internal Medicine. 101: 527-537. PMID 6383165 DOI: 10.7326/0003-4819-101-4-527 |
0.32 |
|
| 1984 |
Hotez PJ, Le Trang N, Fairlamb AH, Cerami A. Lipoprotein lipase suppression in 3T3-L1 cells by a haematoprotozoan-induced mediator from peritoneal exudate cells. Parasite Immunology. 6: 203-9. PMID 6377200 DOI: 10.1111/J.1365-3024.1984.Tb00793.X |
0.466 |
|
| 1983 |
Hotez PJ, Cerami A. Secretion of a proteolytic anticoagulant by Ancylostoma hookworms. The Journal of Experimental Medicine. 157: 1594-603. PMID 6343546 DOI: 10.1084/Jem.157.5.1594 |
0.438 |
|
| 1983 |
Brownlee M, Vlassara H, Cerami A. Nonenzymatic glycosylation reduces the susceptibility of fibrin to degradation by plasmin Diabetes. 37: 680-684. PMID 6222931 DOI: 10.2337/Diab.32.7.680 |
0.312 |
|
| 1982 |
Monnier VM, Cerami A. 7 Non-enzymatic glycosylation and browning of proteins in diabetes Clinics in Endocrinology and Metabolism. 11: 431-452. PMID 6754164 DOI: 10.1016/S0300-595X(82)80023-6 |
0.321 |
|
| 1982 |
Monnier VM, Cerami A. Nonenzymatic glycosylation and browning in diabetes and aging. Studies on lens proteins Diabetes. 31: 57-63. DOI: 10.2337/Diab.31.3.S57 |
0.301 |
|
| 1968 |
Klett RP, Cerami A, Reich E. Exonuclease VI, a new nuclease activity associated with E. coli DNA polymerase. Proceedings of the National Academy of Sciences of the United States of America. 60: 943-50. PMID 4875807 DOI: 10.1073/PNAS.60.3.943 |
0.376 |
|
| 1968 |
Beers W, Cerami A, Reich E. An experimental model for internal denaturation of linear DNA molecules. Proceedings of the National Academy of Sciences of the United States of America. 58: 1624-31. PMID 4295830 DOI: 10.1073/PNAS.58.4.1624 |
0.372 |
|
| 1967 |
Cerami A, Reich E, Ward DC, Goldberg IH. The interaction of actinomycin with DNA: requirement for the 2-amino group of purines. Proceedings of the National Academy of Sciences of the United States of America. 57: 1036-42. PMID 5340584 DOI: 10.1073/Pnas.57.4.1036 |
0.517 |
|
| Show low-probability matches. |